From Name:
From Email:
To Name:
To Email:

Optional Message:


Isis participates in new startup company developing novel
medicines from natural sources


from pharmabiz.com

Isis Innovation Ltd, the technology transfer company of the University of Oxford, has announced its participation in the formation of IXO Therapeutics Ltd, a new biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases. The new company, a startup from the Natural Environment Research Council and focused on the development of Intellectual Property derived from both NERC and the University of Oxford, aims to develop recombinant protein products that will treat inflammation and diseases that affect the body's immune system. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063